Beta carotene antioxydants

Cardiovascular prevention

All type of patients: 7 trials - ATBC beta carotene - CARET beta carotene - SCP beta carotene - NSCP (Green) beta carotene - PHS beta carotene - WHS beta carotene - WACS beta-caroten

No demonstrated result

suggested cardiovascular events by 31% (not demonstrated)

suggested Cardiovascular death by 28% (not demonstrated)

suggested stroke (fatal and non fatal) by 74% (not demonstrated)

suggested Coronary event by 80% (not demonstrated)

suggested All cause death by 15% (not demonstrated)

See more clinical conditions

Primary prevention: 4 trials - ATBC beta carotene - CARET beta carotene - PHS beta carotene - WHS beta carotene

No demonstrated result

suggested cardiovascular events by 68% (not demonstrated)

suggested Cardiovascular death by 33% (not demonstrated)

suggested stroke (fatal and non fatal) by 86% (not demonstrated)

suggested Coronary event by 88% (not demonstrated)

suggested All cause death by 26% (not demonstrated)

Secondary prevention: 2 trials - WACS beta-caroten - ATBC 2nd prev subgroup (b carotene)

No demonstrated result